Trained immunity and the regulation of anti-fungal defense
Trained immunity and the regulation of anti-fungal defense
批准号:
10557883
负责人:
Amariliz Rivera
金额:
$63.08万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-02-01 至 2027-01-31
关键词:
Acquired Immunodeficiency SyndromeAddressAffectAlveolar MacrophagesAntifungal AgentsAspergillosisAspergillus fumigatusCellsCessation of lifeClinicalCritical PathwaysCryptococcosisCryptococcus gattiiCryptococcus neoformansDataDefectDevelopmentDrug resistanceEmbryoEpigenetic ProcessExhibitsExposure toFungal VaccinesFutureGene TargetingGenetic TranscriptionHealthHost Defense MechanismIFNAR1 geneImmuneImmunityImmunizationImmunocompromised HostImmunosuppressionIn VitroInfectionInfection ControlInflammationInterferonsInterventionLifeLiteratureLungLung infectionsMacrophageMediatorMedicalMoldsMusMycosesNatural ImmunityOpportunistic InfectionsPathway interactionsPatient-Focused OutcomesPatientsPhagocytesPharmaceutical PreparationsPopulationPredispositionPublishingRecording of previous eventsRegulationRoleSTAT1 geneShapesSiblingsSignal TransductionSourceStimulusSystems BiologyT-LymphocyteTestingTherapeuticTissuesTrainingVaccinescross immunitycytokinefungusimmunogenicimprovedin vivoinsightloss of functionlung pathogenmonocytemortalityneutrophilnovelpathogenpathogenic fungusresponsevaccine candidate
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract:
Although often overlooked as a significant health problem, pulmonary infections with fungal pathogens present
a clinical problem of growing concern. Aspergillus fumigatus (Af) and Cryptococcus neoformans (Cn) are two
clinically important fungal pathogens that affect immunosuppressed patients worldwide. Both infections are
difficult to treat and are associated with high mortality rates. A better understanding of immune mechanisms of
host defense against fungi hold the promise of providing the basis for the future development of novel, immune
based interventions to improve patient outcomes. Pulmonary macrophages are critical, front-line mediators of
host protection against fungi and other pulmonary pathogens. Despite the well-defined role of lung macrophages
as crucial initiators of immunity to diverse sets of pathogens, our understanding of how previous infection history
shapes subsequent macrophage responses to fungal infection in the lung remain poorly defined. Moreover, an
emerging body of literature has now revealed that macrophage populations in the lung are more heterogeneous
than originally appreciated and can undergo innate training; an enhanced response to diverse secondary
challenges. It is now also understood that alveolar macrophages present in the lung can originate from embryonic
precursors (tissue-derived alveolar macrophages-TD-AMs) or from blood monocytes (monocyte-derived alveolar
macrophages-Mo-AMs). Whether TD-AM and Mo-AM are equally capable of undergoing innate training is
currently unclear. It is also unknown whether innate training is a conserved response to any infectious stimuli or
regulated by specific pathways. In preliminary studies, we uncovered that priming with an immunogenic strain of
Cn (HK-fbp1) could confer heterologous protection against infection with Af even in the context of drug-induced
immunosuppression and in a T cell-independent manner. Preliminary data gathered, suggest that neutrophils
and STAT1-dependent signals are important regulators of antifungal monocytes and their differentiation into
monocyte-derived cells. Based on our aggregate observations, the central hypothesis of this project is that:
CCR2+mo are critical mediators of antifungal immunity and can be instructed by HK-fbp1 into trained mo-AM via
the coordinated actions of neutrophils and an interferon (IFN) cascade. We will address two related but
independent aims: Aim 1: Investigate the impact of HK-fbp1 immunization to pulmonary innate cell priming and
training to promote antifungal immunity; Aim 2: Decipher the contributions of neutrophils in the regulation of
antifungal trained immunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
-
批准号:10793773
-
项目类别:
-
资助金额:$2.27万
-
财政年份:2019
-
负责人:Amariliz Rivera
-
依托单位:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
-
批准号:10574561
-
项目类别:
-
资助金额:$74.98万
-
财政年份:2019
-
负责人:Amariliz Rivera
-
依托单位:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
-
批准号:10542652
-
项目类别:
-
资助金额:$7.14万
-
财政年份:2019
-
负责人:Amariliz Rivera
-
依托单位:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
-
批准号:10097978
-
项目类别:
-
资助金额:$74.98万
-
财政年份:2019
-
负责人:Amariliz Rivera
-
依托单位:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
-
批准号:10335166
-
项目类别:
-
资助金额:$74.98万
-
财政年份:2019
-
负责人:Amariliz Rivera
-
依托单位:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
-
批准号:9886185
-
项目类别:
-
资助金额:$74.98万
-
财政年份:2019
-
负责人:Amariliz Rivera
-
依托单位:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
-
批准号:10274411
-
项目类别:
-
资助金额:$4.86万
-
财政年份:2019
-
负责人:Amariliz Rivera
-
依托单位:
Regulation of antifungal immunity by monocyte-derived dendritic cells
-
批准号:9263884
-
项目类别:
-
资助金额:$36.2万
-
财政年份:2015
-
负责人:Amariliz Rivera
-
依托单位:
Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development
-
批准号:8701013
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2013
-
负责人:Amariliz Rivera
-
依托单位:
Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development
-
批准号:8637016
-
项目类别:
-
资助金额:$16.77万
-
财政年份:2013
-
负责人:Amariliz Rivera
-
依托单位:
Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development
-
批准号:8494218
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:Amariliz Rivera
-
依托单位:
CD4+ T cells in Invasive Aspergillosis
-
批准号:8164951
-
项目类别:
-
资助金额:$18.62万
-
财政年份:2011
-
负责人:Amariliz Rivera
-
依托单位:
CD4+ T cells in Invasive Aspergillosis
-
批准号:8320974
-
项目类别:
-
资助金额:$14.94万
-
财政年份:2011
-
负责人:Amariliz Rivera
-
依托单位:
CD4+ T cells in Invasive Aspergillosis
-
批准号:8701011
-
项目类别:
-
资助金额:$3.68万
-
财政年份:2011
-
负责人:Amariliz Rivera
-
依托单位:
Aspergillus-specific CD4+ T cells in Invasive Aspergillosis
-
批准号:7142098
-
项目类别:
-
资助金额:$10.82万
-
财政年份:2006
-
负责人:Amariliz Rivera
-
依托单位:
Aspergillus-specific CD4+ T cells in Invasive Aspergillosis
-
批准号:7249435
-
项目类别:
-
资助金额:$11.04万
-
财政年份:2006
-
负责人:Amariliz Rivera
-
依托单位:
Aspergillus-specific CD4+ T cells in Invasive Aspergillosis
-
批准号:7648028
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2006
-
负责人:Amariliz Rivera
-
依托单位:
Aspergillus-specific CD4+ T cells in Invasive Aspergillosis
-
批准号:7449762
-
项目类别:
-
资助金额:$11.28万
-
财政年份:2006
-
负责人:Amariliz Rivera
-
依托单位:
Aspergillus-specific CD4+ T cells in Invasive Aspergillosis
-
批准号:8205904
-
项目类别:
-
资助金额:$14.14万
-
财政年份:2006
-
负责人:Amariliz Rivera
-
依托单位:
Aspergillus-specific CD4+ T cells in Invasive Aspergillosis
-
批准号:7879326
-
项目类别:
-
资助金额:$1.13万
-
财政年份:2006
-
负责人:Amariliz Rivera
-
依托单位:
海外基金